๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2025-12-21

Detection of Early Idiopathic Pulmonary Fibrosis (NCT03457935)

The Role of the miR200 Family in the Restoration of Normal Lung Homeostasis and Detection of Early IPF

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: Temple University

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of the study is to determine if miR200 family may serve as a biomarker of IPF.

Who can join: Review the eligibility criteria below.

Location: Temple University โ€” Philadelphia, Pennsylvania

Age range: 18 Years

๐Ÿงช Interventions in This Study

  • blood samples (OTHER)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Temple University โ€” Philadelphia, Pennsylvania

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—